ASX - By Stock
|
SPL |
Re:
Unloved at the moment
|
|
AHS
|
19 |
4.3K |
0 |
04/05/24 |
04/05/24 |
ASX - By Stock
|
19
|
4.3K
|
0
|
|
ASX - By Stock
|
SPL |
Re:
Unloved at the moment
|
|
AHS
|
19 |
4.3K |
2 |
03/05/24 |
03/05/24 |
ASX - By Stock
|
19
|
4.3K
|
2
|
|
ASX - By Stock
|
SPL |
Re:
Unloved at the moment
|
|
AHS
|
19 |
4.3K |
1 |
03/05/24 |
03/05/24 |
ASX - By Stock
|
19
|
4.3K
|
1
|
|
ASX - By Stock
|
SPL |
Re:
Ann: Starpharma completes oversubscribed A$45M placement
|
|
AHS
|
43 |
16K |
0 |
03/05/24 |
03/05/24 |
ASX - By Stock
|
43
|
16K
|
0
|
|
ASX - By Stock
|
SPL |
Re:
Ann: Starpharma completes oversubscribed A$45M placement
|
|
AHS
|
43 |
16K |
0 |
03/05/24 |
03/05/24 |
ASX - By Stock
|
43
|
16K
|
0
|
|
ASX - By Stock
|
SPL |
Re:
Blackout Period
|
|
AHS
|
24 |
4.8K |
1 |
02/05/24 |
02/05/24 |
ASX - By Stock
|
24
|
4.8K
|
1
|
|
ASX - By Stock
|
SPL |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
AHS
|
52 |
8.9K |
0 |
30/04/24 |
30/04/24 |
ASX - By Stock
|
52
|
8.9K
|
0
|
|
ASX - By Stock
|
SPL |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
AHS
|
52 |
8.9K |
1 |
30/04/24 |
30/04/24 |
ASX - By Stock
|
52
|
8.9K
|
1
|
|
ASX - By Stock
|
SPL |
Re:
Is it finally time to buy???
|
|
AHS
|
7 |
1.6K |
0 |
26/04/24 |
26/04/24 |
ASX - By Stock
|
7
|
1.6K
|
0
|
|
ASX - By Stock
|
SPL |
Re:
ASCO Presentations 2024
|
|
AHS
|
29 |
5.6K |
4 |
26/04/24 |
26/04/24 |
ASX - By Stock
|
29
|
5.6K
|
4
|
|
ASX - By Stock
|
SPL |
Re:
SPL chart
|
|
AHS
|
451 |
139K |
1 |
22/04/24 |
22/04/24 |
ASX - By Stock
|
451
|
139K
|
1
|
|
ASX - By Stock
|
SPL |
Re:
Ann: Change in Director's Interest Notice - R Thomas
|
|
AHS
|
22 |
4.1K |
0 |
16/04/24 |
16/04/24 |
ASX - By Stock
|
22
|
4.1K
|
0
|
|
ASX - By Stock
|
SPL |
Re:
Ann: Change in Director's Interest Notice - R Thomas
|
|
AHS
|
22 |
4.1K |
3 |
15/04/24 |
15/04/24 |
ASX - By Stock
|
22
|
4.1K
|
3
|
|
ASX - By Stock
|
SPL |
Re:
Ann: Change in Director's Interest Notice - R Thomas
|
|
AHS
|
22 |
4.1K |
4 |
15/04/24 |
15/04/24 |
ASX - By Stock
|
22
|
4.1K
|
4
|
|
ASX - By Stock
|
SPL |
Confirmation Bias
|
|
AHS
|
3 |
536 |
2 |
11/04/24 |
11/04/24 |
ASX - By Stock
|
3
|
536
|
2
|
|
ASX - By Stock
|
SPL |
Re:
Ann: Starpharma and Medicxi Partnership Petalion Therapeutics
|
|
AHS
|
148 |
28K |
6 |
10/04/24 |
10/04/24 |
ASX - By Stock
|
148
|
28K
|
6
|
|
ASX - By Stock
|
SPL |
Re:
Ann: Starpharma and Medicxi Partnership Petalion Therapeutics
|
|
AHS
|
148 |
28K |
4 |
09/04/24 |
09/04/24 |
ASX - By Stock
|
148
|
28K
|
4
|
|
ASX - By Stock
|
SPL |
Re:
Starpharma's website has been updated
|
|
AHS
|
23 |
5.3K |
3 |
22/03/24 |
22/03/24 |
ASX - By Stock
|
23
|
5.3K
|
3
|
|
ASX - By Stock
|
SPL |
Re:
Starpharma's website has been updated
|
|
AHS
|
23 |
5.3K |
2 |
22/03/24 |
22/03/24 |
ASX - By Stock
|
23
|
5.3K
|
2
|
|
ASX - By Stock
|
SPL |
Re:
History
|
|
AHS
|
83 |
15K |
0 |
20/03/24 |
20/03/24 |
ASX - By Stock
|
83
|
15K
|
0
|
|
ASX - By Stock
|
SPL |
Re:
The blackout period remains in place
|
|
AHS
|
18 |
3.2K |
1 |
15/03/24 |
15/03/24 |
ASX - By Stock
|
18
|
3.2K
|
1
|
|
ASX - By Stock
|
SPL |
Re:
Tough start for the new CEO
|
|
AHS
|
12 |
2.8K |
3 |
13/03/24 |
13/03/24 |
ASX - By Stock
|
12
|
2.8K
|
3
|
|
ASX - By Stock
|
SPL |
Re:
Uk marketing with Amazon interesting
|
|
AHS
|
56 |
8.5K |
2 |
06/03/24 |
06/03/24 |
ASX - By Stock
|
56
|
8.5K
|
2
|
|
ASX - By Stock
|
SPL |
Re:
Uk marketing with Amazon interesting
|
|
AHS
|
56 |
8.5K |
1 |
06/03/24 |
06/03/24 |
ASX - By Stock
|
56
|
8.5K
|
1
|
|
ASX - By Stock
|
SPL |
Re:
Ann: S&P DJI Announces March 2024 Quarterly Rebalance
|
|
AHS
|
27 |
6.3K |
0 |
01/03/24 |
01/03/24 |
ASX - By Stock
|
27
|
6.3K
|
0
|
|
ASX - By Stock
|
SPL |
Re:
The comical commercialisation history of VivaGel BV
|
|
AHS
|
12 |
2.9K |
5 |
07/02/24 |
07/02/24 |
ASX - By Stock
|
12
|
2.9K
|
5
|
|
ASX - By Stock
|
SPL |
Re:
Good news!
|
|
AHS
|
13 |
3.5K |
3 |
03/02/24 |
03/02/24 |
ASX - By Stock
|
13
|
3.5K
|
3
|
|
ASX - By Stock
|
SPL |
Re:
Good news!
|
|
AHS
|
13 |
3.5K |
0 |
02/02/24 |
02/02/24 |
ASX - By Stock
|
13
|
3.5K
|
0
|
|
ASX - By Stock
|
SPL |
Re:
Good news!
|
|
AHS
|
13 |
3.5K |
3 |
02/02/24 |
02/02/24 |
ASX - By Stock
|
13
|
3.5K
|
3
|
|
ASX - By Stock
|
SPL |
Re:
Good news!
|
|
AHS
|
13 |
3.5K |
1 |
02/02/24 |
02/02/24 |
ASX - By Stock
|
13
|
3.5K
|
1
|
|
ASX - By Stock
|
SPL |
Re:
May New Year bring good Viraleze news and SPL
|
|
AHS
|
11 |
2.7K |
3 |
02/01/24 |
02/01/24 |
ASX - By Stock
|
11
|
2.7K
|
3
|
|
ASX - By Stock
|
SPL |
Re:
Ann: Positive DEP docetaxel Phase 2 results
|
|
AHS
|
131 |
27K |
0 |
27/12/23 |
27/12/23 |
ASX - By Stock
|
131
|
27K
|
0
|
|
ASX - By Stock
|
SPL |
Re:
The waiting game and countdown continues
|
|
AHS
|
36 |
8.7K |
5 |
22/12/23 |
22/12/23 |
ASX - By Stock
|
36
|
8.7K
|
5
|
|
ASX - By Stock
|
SPL |
Re:
Ann: Positive DEP docetaxel Phase 2 results
|
|
AHS
|
131 |
27K |
1 |
21/12/23 |
21/12/23 |
ASX - By Stock
|
131
|
27K
|
1
|
|
ASX - By Stock
|
SPL |
Re:
AstraZeneca: Acquisitions And Some Thoughts About Biotech Investing
|
|
AHS
|
18 |
4.5K |
4 |
20/12/23 |
20/12/23 |
ASX - By Stock
|
18
|
4.5K
|
4
|
|
ASX - By Stock
|
SPL |
Re:
REBIRTH OR REINVENTION OF STARPHARMA
|
|
AHS
|
38 |
9.2K |
1 |
07/12/23 |
07/12/23 |
ASX - By Stock
|
38
|
9.2K
|
1
|
|
ASX - By Stock
|
SPL |
Re:
Could we pleasantly be surprised at AGM
|
|
AHS
|
34 |
7.4K |
2 |
01/12/23 |
01/12/23 |
ASX - By Stock
|
34
|
7.4K
|
2
|
|
ASX - By Stock
|
SPL |
Re:
Is this finally the start of run
|
|
AHS
|
30 |
7.4K |
0 |
20/11/23 |
20/11/23 |
ASX - By Stock
|
30
|
7.4K
|
0
|
|
ASX - By Stock
|
SPL |
Re:
Ann: Starpharma announces new CEO, Ms Cheryl Maley
|
|
AHS
|
91 |
23K |
0 |
17/11/23 |
17/11/23 |
ASX - By Stock
|
91
|
23K
|
0
|
|
ASX - By Stock
|
SPL |
Re:
Ann: Starpharma announces new CEO, Ms Cheryl Maley
|
|
AHS
|
91 |
23K |
0 |
17/11/23 |
17/11/23 |
ASX - By Stock
|
91
|
23K
|
0
|
|
ASX - By Stock
|
SPL |
Re:
Ann: Starpharma announces new CEO, Ms Cheryl Maley
|
|
AHS
|
91 |
23K |
0 |
17/11/23 |
17/11/23 |
ASX - By Stock
|
91
|
23K
|
0
|
|
ASX - By Stock
|
SPL |
Re:
World Leader???
|
|
AHS
|
1 |
360 |
2 |
13/11/23 |
13/11/23 |
ASX - By Stock
|
1
|
360
|
2
|
|
ASX - By Stock
|
SPL |
Re:
Catalysts and/or inflection points
|
|
AHS
|
6 |
1.3K |
0 |
03/11/23 |
03/11/23 |
ASX - By Stock
|
6
|
1.3K
|
0
|
|
ASX - By Stock
|
SPL |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
AHS
|
32 |
7.4K |
2 |
31/10/23 |
31/10/23 |
ASX - By Stock
|
32
|
7.4K
|
2
|
|
ASX - By Stock
|
SPL |
Re:
Ann: Notice of Annual General Meeting/Proxy Form
|
|
AHS
|
36 |
8.4K |
6 |
30/10/23 |
30/10/23 |
ASX - By Stock
|
36
|
8.4K
|
6
|
|
ASX - By Stock
|
SPL |
Re:
Ann: Notice of Annual General Meeting/Proxy Form
|
|
AHS
|
36 |
8.4K |
1 |
29/10/23 |
29/10/23 |
ASX - By Stock
|
36
|
8.4K
|
1
|
|
ASX - By Stock
|
SPL |
Re:
Ann: Notice of Annual General Meeting/Proxy Form
|
|
AHS
|
36 |
8.4K |
0 |
28/10/23 |
28/10/23 |
ASX - By Stock
|
36
|
8.4K
|
0
|
|
ASX - By Stock
|
SPL |
Re:
Ann: Notice of Annual General Meeting/Proxy Form
|
|
AHS
|
36 |
8.4K |
1 |
28/10/23 |
28/10/23 |
ASX - By Stock
|
36
|
8.4K
|
1
|
|
ASX - By Stock
|
SPL |
Re:
Ann: Positive DEP Cabazitaxel Phase 2 Results in Multiple Cancer
|
|
AHS
|
73 |
18K |
0 |
18/10/23 |
18/10/23 |
ASX - By Stock
|
73
|
18K
|
0
|
|
ASX - By Stock
|
SPL |
Re:
Ann: Application for quotation of securities - SPL
|
|
AHS
|
3 |
1.1K |
0 |
09/10/23 |
09/10/23 |
ASX - By Stock
|
3
|
1.1K
|
0
|
|